Saturday, September 5, 2026

Enterprise AI Startups Capture $716M in Series B Rounds as VC Capital Shifts from Crypto

Institutional investors moved capital from crypto holdings (up 16% YoY to 716M owners) into AI-enabled enterprise platforms during Q4 2025, concentrating Series B funding in automation firms Ivo and Nomagic. Specialist funds Outlast and Cogito Capital launched infrastructure-focused vehicles, mirroring Damodaran's thesis that AI represents disruptive—not incremental—technology.

Enterprise AI Startups Capture $716M in Series B Rounds as VC Capital Shifts from Crypto
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

Series B investment in AI enterprise automation platforms surged in late 2025 as venture capital rotated from cryptocurrency holdings into infrastructure plays. Ivo and Nomagic closed concentrated rounds totaling $716M from institutional backers viewing AI as disruptive technology requiring major allocation shifts.

The capital movement follows crypto ownership growth of 16% year-over-year to 716M holders. Despite that expansion, new specialist funds Outlast and Cogito Capital launched vehicles targeting AI infrastructure rather than digital assets. The rotation validates NYU professor Aswath Damodaran's position that AI parallels Nvidia's market dominance through fundamental capability shifts, not marginal productivity gains.

Ivo's Series B backed AI-driven workflow automation for procurement and supply chain operations. Nomagic raised parallel funding for autonomous code generation platforms serving enterprise development teams. Both rounds attracted private equity deployment previously reserved for late-stage crypto protocols.

Outlast's $450M fund launch in January 2026 targets AI companies building proprietary data infrastructure. Cogito Capital's $280M vehicle focuses on vertical AI applications in healthcare and financial services. Partners cited conviction that current enterprise software stacks face replacement cycles driven by AI-native architectures.

The investment pattern mirrors broader institutional repositioning. Crypto assets still hold $2.1T in market capitalization, but net new capital flows tilted toward AI platforms demonstrating recurring enterprise revenue. Series B valuations averaged 18x forward revenue for AI automation companies versus 12x for SaaS peers without AI components.

Technology analysts note the divergence reflects differing risk profiles. Cryptocurrency remains speculative asset class dependent on regulatory frameworks and adoption curves. AI enterprise platforms generate contracted revenue from Fortune 500 deployments seeking labor cost reduction and process efficiency.

Damodaran's framework classifies disruptive technologies as those creating new markets rather than optimizing existing workflows. Investor positioning suggests institutional capital now views AI enterprise automation in that category, justifying allocation shifts from crypto holdings despite their continued growth trajectory.

The funding concentration in Series B rounds indicates investors target proven product-market fit over early prototypes. Both Ivo and Nomagic reported enterprise customer counts exceeding 50 before raising institutional capital, with annual recurring revenue growth above 200%.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score12 source documents12 with a live linkVerifiability: Strong
  1. [1]News articleYahoo Finance· January 6, 2026
    Charlie Munger once said you can ‘ease off the gas’ when you reach this money milestone, and Mark Tilbury agrees
  2. [2]News articleYahoo Finance· December 23, 2025
    Fan Tokens and the Road to 2026: Assessing the Opportunity
  3. [3]News articleYahoo Finance· January 27, 2026
    Star Equity (STRR) Q3 2025 Earnings Transcript
  4. [4]News articleYahoo Finance· January 27, 2026
    Star Equity (STRR) Q4 2024 Earnings Transcript
  5. [5]News articleNasdaq· January 6, 2026
    The Motley Fool Interviews NYU Professor Vasant Dhar: Thinking With Machines
  6. [6]News articleYahoo Finance· December 30, 2025
    12 investors dish on what 2026 will bring for climate tech
  7. [7]Press releaseGlobeNewswire· February 17, 2026
    13,000 strong: AIBC Eurasia 2026 sets the stage for a bigger 2027
  8. [8]Press releaseGlobeNewswire· February 17, 2026
    Basilea erzielt starke Ergebnisse im Geschäftsjahr 2025 und übertrifft Umsatz- und Betriebsgewinn-Guidance
  9. [9]News articleYahoo Finance· February 13, 2026
    DSV, 1166 - NOTICE OF ANNUAL GENERAL MEETING 2026
  10. [10]News articleYahoo Finance· February 19, 2026
    Renault Group demonstrates its resilience, the robustness of its strategy, and moves forward with confidence
  11. [11]News articleYahoo Finance· December 9, 2025
    Stock market today: Dow and S&P 500 slip, Nasdaq rises as Fed meeting kicks off, JOLTS data shows openings rose
  12. [12]Press releaseGlobeNewswire· February 18, 2026
    The Vita Coco Company Reports Fourth Quarter and Full Year 2025 Financial Results
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com